Integrated Core Strategies (US) LLC 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Integrated Core Strategies (US) LLC | 102,848 0.600% |
-749,694![]() (-87.94%) |
Filing |